Get the Stockscreener App
151.65
2.25%
-3.49
After Hours:
151.65
Davita Inc stock is traded at $151.65, with a volume of 579.44K.
It is down -2.25% in the last 24 hours and up +0.87% over the past month.
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
See More
Previous Close:
$155.14
Open:
$154.87
24h Volume:
579.44K
Relative Volume:
0.59
Market Cap:
$10.00B
Revenue:
$13.64B
Net Income/Loss:
$1.05B
P/E Ratio:
15.87
EPS:
9.555
Net Cash Flow:
$1.31B
1W Performance:
-0.13%
1M Performance:
+0.87%
6M Performance:
+27.42%
1Y Performance:
+7.98%
1-Day Range:
$151.27
$155.84
1-Week Range:
$149.35
$155.84
52-Week Range:
$101.00
$159.42
Davita Inc Stock (DVA) Company Profile
Name
Davita Inc
Sector
Industry
Phone
310-536-2668
Address
2000 16TH STREET, DENVER, CO
Compare DVA vs HCA, THC, FMS, ENSG, EHC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
151.65 | 10.23B | 13.64B | 1.05B | 1.31B | 9.555 |
HCA
Hca Healthcare Inc
|
433.09 | 96.38B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
183.27 | 15.52B | 21.46B | 2.65B | 3.32B | 19.23 |
FMS
Fresenius Medical Care Ag Adr
|
22.49 | 12.33B | 22.18B | 1.36B | 2.00B | 1.9216 |
ENSG
Ensign Group Inc
|
183.72 | 10.91B | 5.06B | 344.26M | 370.71M | 5.8446 |
EHC
Encompass Health Corp
|
107.48 | 9.94B | 5.94B | 758.60M | 439.20M | 5.5418 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Aug-07-23 | Upgrade | UBS | Neutral → Buy |
| Nov-01-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-31-22 | Downgrade | UBS | Buy → Neutral |
| Aug-19-22 | Resumed | UBS | Buy |
| Jun-21-22 | Reiterated | BofA Securities | Underperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Aug-12-21 | Downgrade | Barclays | Overweight → Equal Weight |
| Mar-26-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Jan-05-21 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-24-20 | Upgrade | Goldman | Neutral → Buy |
| Nov-07-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Oct-25-19 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Sep-11-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-26-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-08-19 | Upgrade | UBS | Sell → Neutral |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Dec-14-18 | Initiated | Barclays | Overweight |
| Nov-28-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Nov-16-18 | Initiated | UBS | Sell |
| Nov-08-18 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Sep-13-18 | Upgrade | JP Morgan | Underweight → Neutral |
| Jan-04-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Dec-12-17 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Dec-11-17 | Upgrade | Citigroup | Neutral → Buy |
| Dec-07-17 | Upgrade | Raymond James | Outperform → Strong Buy |
| Nov-08-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Oct-09-17 | Downgrade | JP Morgan | Neutral → Underweight |
| Jun-26-17 | Downgrade | Jefferies | Buy → Hold |
| Dec-13-16 | Downgrade | Robert W. Baird | Outperform → Neutral |
View All
Davita Inc Stock (DVA) Latest News
Can Execution and Volume Trends Support DaVita's Q1 Earnings? - Yahoo Finance
Here is What to Know Beyond Why DaVita Inc. (DVA) is a Trending Stock - Yahoo Finance
Universal Beteiligungs und Servicegesellschaft mbH Sells 12,843 Shares of DaVita Inc. $DVA - MarketBeat
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
DaVita Inc. Stock (US23918K1088): Q1 2026 Earnings Release on Track for April 30 - AD HOC NEWS
DaVita HealthCare (DVA) Ascends While Market Falls: Some Facts to Note - Yahoo Finance
How Analyst Model Shifts Are Rewriting The DaVita (DVA) Investment Narrative - Yahoo Finance
Early Integrated Kidney Care Profitability Could Be A Game Changer For DaVita (DVA) - Sahm
Evaluating Innovations in Middle Molecule Clearance - DaVita Newsroom
M&T Bank Corp Acquires 19,500 Shares of DaVita Inc. $DVA - MarketBeat
DaVita Inc. stock underperforms Monday when compared to competitors - MarketWatch
Why did DaVita stock jump 15% after hours today? - MSN
DaVita Inc. (DVA) Stock Analysis: Navigating the Healthcare Sector with Strong Revenue Growth and High ROE - DirectorsTalk Interviews
DVA Stock Price, Quote & Chart | DAVITA INC (NYSE:DVA) - ChartMill
Teachers Retirement System of The State of Kentucky Has $21.29 Million Stock Holdings in DaVita Inc. $DVA - MarketBeat
DaVita Inc (BSP:DVAI34) Stock Price & 30 Year Financial Data - GuruFocus
DaVita Inc. $DVA Stock Position Decreased by Mirae Asset Global Investments Co. Ltd. - MarketBeat
Asset Management One Co. Ltd. Cuts Stock Holdings in DaVita Inc. $DVA - MarketBeat
DaVita’s Profitable Kidney Care Platform Recasts Value Based Growth Story - Sahm
DaVita Q4 2025 earnings preview - MSN
DaVita Inc. stock underperforms Friday when compared to competitors - MarketWatch
Is It Time To Reassess DaVita (DVA) After Its Strong Year To Date Rally? - simplywall.st
DaVita Inc Forecasts Strong EPS Growth Ahead of Q1 2026 Earnings - HarianBasis.co
What’s So Good About DaVita (DVA) That Warren Buffett Remains Bullish On It Since 15 Years? - Insider Monkey
Here's why you should retain DaVita stock in your portfolio for now - MSN
Dialysis Giant DaVita Defends Itself In Court And At The Polls - KFF Health News
DaVita HealthCare (DVA) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance
DaVita Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
DaVita (NYSE: DVA) details 2026 virtual meeting, board slate and say-on-pay - Stock Titan
What to Expect From DaVita's Next Quarterly Earnings Report - Yahoo Finance
DaVita Inc. stock (US23918K1088): Why does its dialysis dominance still drive U.S. investor value? - AD HOC NEWS
Outpatient & Specialty Care Stocks Q4 Earnings Review: DaVita (NYSE:DVA) Shines - Yahoo Finance
DaVita Inc. (NYSE:DVA) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Sumitomo Mitsui Trust Group Inc. Has $203,000 Position in DaVita Inc. $DVA - MarketBeat
Lobbying Update: $1,200,000 of DAVITA INC lobbying was just disclosed - Quiver Quantitative
DaVita Inc. Schedules 1st Quarter 2026 Investor Conference Call - The Malaysian Reserve
DaVita (DVA) Stock: Support and Resistance Zones (Touches High) 2026-04-20Retail Picks - Cổng thông tin điện tử tỉnh Tây Ninh
DaVita Inc stock (US23804L1035): Is its dialysis network dominance the real long-term edge? - AD HOC NEWS
Kidney Dialysis Equipment Market Is Booming So Rapidly| Davita - openPR.com
DaVita Inc. (DVA) Stock Analysis: Navigating Growth With A 64.85% Return On Equity - DirectorsTalk Interviews
DaVita Inc stock (US23804L1035): Why Google Discover changes matter more now - AD HOC NEWS
DaVita Clinical Research Celebrates Milestone Year - Yahoo
Lecap Asset Management Ltd. Invests $992,000 in DaVita Inc. $DVA - MarketBeat
KBC Group NV Raises Position in DaVita Inc. $DVA - MarketBeat
DaVita Inc (DVA) Shares Fall 3.3% -- What GF Score of 92 Tells I - GuruFocus
DaVita HealthCare (DVA) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance
DaVita Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
DaVita Inc. stock (US23918K1088): Is kidney care demand strong enough to drive steady investor retur - AD HOC NEWS
DaVita Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
DaVita Inc. stock rises Monday, still underperforms market - MarketWatch
DaVita Inc stock (US23804L1035): Why its kidney care dominance matters more now for investors - AD HOC NEWS
Davita Inc Stock (DVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Davita Inc Stock (DVA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| ACKERMAN JOEL | CFO and Treasuer |
Feb 06 '26 |
Option Exercise |
108.93 |
44,065 |
4,800,000 |
185,705 |
| BERKSHIRE HATHAWAY INC | 10% Owner |
Jan 29 '26 |
Sale |
120.56 |
1,658,480 |
199,939,881 |
30,100,585 |
| HEARTY JAMES O | Chief Compliance Officer |
Dec 04 '25 |
Option Exercise |
108.93 |
5,875 |
639,964 |
31,913 |
| BERKSHIRE HATHAWAY INC | 10% Owner |
Oct 27 '25 |
Sale |
135.36 |
401,514 |
54,347,249 |
31,759,065 |
| BERKSHIRE HATHAWAY INC | 10% Owner |
Jul 31 '25 |
Sale |
140.61 |
1,635,962 |
230,024,764 |
32,160,579 |
| HEARTY JAMES O | Chief Compliance Officer |
Jul 23 '25 |
Sale |
150.00 |
2,351 |
352,650 |
26,038 |
0.75%
7.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):